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To the Editor,
Although syphilis coinfection is a known risk factor for heterosexual transmission of HIV
[1,2], its role in mother-to-child transmission (MTCT) is unclear [3-5]. We investigated
the impact of maternal positive syphilis serology on MTCT in the Ukrainian sites of the
European Collaborative Study, a cohort study of HIV-infected pregnant women and their
children; full methods are described elsewhere [6]. The mother-child pairs (MCPs) in this
analysis came from a nested sub-study of sexually transmitted infections (STI) [7]: for
MCPs enrolled from January 2003 to October 2005, STI test results were extracted from
antenatal records and linked to the prospective ECS database; subsequently, one centre
started prospective collection of all antenatal STI test results and MCPs enrolled here
from October 2005 were also included. Antenatal serological screening was performed
with non-trepenomal tests at pregnancy registration and repeated in the third trimester,
with confirmatory testing using trepenomal tests, according to national policy. Infected
women and their infants were treated with penicillin.
Logistic regression was used to investigate MTCT risk factors. Infants with persistence of
HIV antibody beyond 18 months of age and/or a positive HIV PCR test were considered
HIV-infected; infants HIV antibody-negative and/or with two negative PCRs were
classified as uninfected [6]. Variables considered in the multivariable model were
maternal syphilis serology, antiretroviral prophylaxis, elective Caesarean section delivery
and premature delivery (<37 completed gestational weeks) and were retained based on
Akaike's Information Criterion [6]
There were 521 MCPs with known infant HIV infection status. All women were born in
Ukraine, median maternal age was 25.0 years (range, 16.1-43.4) and 66% (n=346)
were nulliparous. Injecting drug use (IDU) history was reported by 20% (105/516)
women; a further 210 (40%) women reported an IDU sexual partner. Overall, 3.5%
(95%CI 2.1-5.4) pregnant women had positive syphilis serology, increasing to 5.7%
(6/105, 95%CI 2.1-12.0) among women with IDU history (a non-significant difference).3
Antenatal CD4 counts were available for 163 (31%) women only, due to limited
laboratory capacity. Median CD4 count was 514 cells/mm
3 (IQR, 350-700) overall, with
no difference by syphilis status. The HIV MTCT rate was 5.8% (30/521, 95% CI 3.9-
8.1%) overall and was significantly higher among women seropositive for syphilis
(
2=6.4, p=0.011) (Table). Positive antenatal syphilis serology was associated with a
five-fold increased MTCT risk univariably and a nearly 4.5-fold increased risk in the
adjusted model (Table).
Our study provides the first evidence of an association between maternal syphilis and
MTCT risk in an Eastern European setting. A limitation is the lack of maternal HIV RNA
quantification in our population, which prevented us from adjusting for this important risk
factor for MTCT [6]. However, in a study in Malawi, maternal syphilis coinfection was
associated with a 2.6-fold increased risk of in utero HIV transmission univariably and 2.7-
fold increased risk independent of maternal viral load [3]. Elimination of congenital
syphilis and “virtual elimination” of HIV transmission to infants are key public health
goals [8-9], and our findings underscore the need for integration of antenatal syphilis
screening and treatment programmes with PMTCT programmes.4
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Table Unadjusted MTCT rates and logistic regression analyses of risk of mother-to-child transmission (n=521)
Unadjusted
MTCT rate
OR (95% CI) p value Adjusted OR (95% CI) p value
Maternal syphilis serology
Negative
Positive
Antenatal / intrapartum ARV prophylaxis
None
Single dose nevirapine only
Antenatal ARV prophylaxis
Premature delivery
No
Yes
Elective Caesarean section delivery
No
Yes
5.2% (26/503)
22.2% (4/18)
23.1% (3/13)
11.1% (8/72)
4.4% (19/436)
5.1% (25/489)
15.6% (5/32)
8.4% (19/226)
3.7% (11/295)
1.00
5.24 (16.1-17.0) p=0.006
1.00
0.42 (0.09-1.84) p=0.25
0.15 (0.04-0.60) p=0.007
1.00
3.44 (1.22-9.68) p=0.02
1.00
0.42 (0.20-0.91) p=0.03
1.00
4.43 (1.31-15.0) p=0.02
1.00
0.41 (0.09-1.88) p=0.25
0.19 (0.05-0.80) p=0.02
1.00
2.21 (0.72-6.83) p=0.17
-
OR, odds ratio; ARV, antiretroviral